These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1729398

  • 1. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
    Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1992 Feb; 58(2):529-41. PubMed ID: 1729398
    [Abstract] [Full Text] [Related]

  • 2. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [Abstract] [Full Text] [Related]

  • 3. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW, Wells FR, Jenner P, Marsden CD.
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [Abstract] [Full Text] [Related]

  • 4. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.
    Rinne JO, Myllykylä T, Lönnberg P, Marjamäki P.
    Brain Res; 1991 Apr 26; 547(1):167-70. PubMed ID: 1860068
    [Abstract] [Full Text] [Related]

  • 5. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO, Lönnberg P, Marjamäki P, Rinne UK.
    Brain Res; 1989 Apr 03; 483(2):402-6. PubMed ID: 2706531
    [Abstract] [Full Text] [Related]

  • 6. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites.
    Araujo DM, Lapchak PA, Meaney MJ, Collier B, Quirion R.
    J Neurosci; 1990 Sep 03; 10(9):3069-78. PubMed ID: 2398371
    [Abstract] [Full Text] [Related]

  • 7. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA, Owens J, O'Brien J, Colloby S, Fenwick J, Wyper D, Jaros E, Johnson M, Perry RH, Perry EK.
    J Chem Neuroanat; 2003 Mar 03; 25(3):161-73. PubMed ID: 12706204
    [Abstract] [Full Text] [Related]

  • 8. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
    Aubert I, Cécyre D, Gauthier S, Quirion R.
    J Comp Neurol; 1996 May 20; 369(1):31-55. PubMed ID: 8723701
    [Abstract] [Full Text] [Related]

  • 9. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK, Smith CJ, Court JA, Perry RH.
    J Neural Transm Park Dis Dement Sect; 1990 May 20; 2(3):149-58. PubMed ID: 2175197
    [Abstract] [Full Text] [Related]

  • 10. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K, Iseki E, Uchiyama H, Watanabe Y, Haga T, Kameyama K, Ikeda T, Yamamoto T, Kosaka K.
    J Neurol Neurosurg Psychiatry; 1999 Aug 20; 67(2):209-13. PubMed ID: 10406992
    [Abstract] [Full Text] [Related]

  • 11. Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients.
    Waller SB, Ball MJ, Reynolds MA, London ED.
    Can J Neurol Sci; 1986 Nov 20; 13(4 Suppl):528-32. PubMed ID: 3791067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK.
    Neuroscience; 2000 Nov 20; 98(1):79-87. PubMed ID: 10858614
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
    Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G.
    J Neurol Neurosurg Psychiatry; 1987 Jun 20; 50(6):806-9. PubMed ID: 2956364
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study.
    Ułas J, Weihmuller FB, Brunner LC, Joyce JN, Marshall JF, Cotman CW.
    J Neurosci; 1994 Nov 20; 14(11 Pt 1):6317-24. PubMed ID: 7965038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.